Public signalCompany raiseAuto-indexed · Unverified
Scorpion Therapeutics, Inc. raised $125.7M
Scorpion Therapeutics, Inc.· Boston, US· Biotechnology· Filed Jul 16, 2024
Scorpion Therapeutics, Inc. reported raising capital. Based in Boston, MASSACHUSETTS, US. First sale reported 2024-07-01. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$125.7M
Confidence90%
Raised
$125.7M
Investors
38
Incorporated
2020
Jurisdiction
DELAWARE
On the record
- Location
- Boston, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $125.7M
- Target amount
- $150.0M
- Filing date
- Jul 16, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2020
- Industry group
- Biotechnology
- Number of investors
- 38
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $150.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Adam Friedman
Executive Officer
Boston, US
Amanda Valentino
Executive Officer
Boston, US
Andrew Fedder
Executive Officer
Boston, US
Arjun Goyal
Director
Boston, US
Brian Piper
Executive Officer
Boston, US
Darrin Stuart
Executive Officer
Boston, US
Erica Jackson
Executive Officer
Boston, US
Jean-Francois Formela
Director
Boston, US
Jeffrey Albers
Director
Boston, US
Keith Flaherty
Director
Boston, US
Mark Chao
Executive Officer
Boston, US
Oleg Nodelman
Director
Boston, US
Otello Stampacchia
Director
Boston, US
Saurabh Saha
Director
Boston, US
Shelley Chu
Director
Lexington, US
Sources & provenance
“Operating company sold 125,694,186 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 16, 2024. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyOver $100MCompany Raise
Are you associated with Scorpion Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record